Glucose 6-P Dehydrogenase Overexpression Improves Aging-Induced Endothelial Dysfunction in Aorta from Mice: Role of Arginase II.
Eva SernaMaria D MauricioTeresa San-MiguelSol Guerra-OjedaDavid VerdúAlicia VallsCoralie Arc-ChagnaudAdrián De la RosaJosé ViñaPublished in: International journal of molecular sciences (2023)
The increase of vascular arginase activity during aging causes endothelial dysfunction. This enzyme competes with the endothelial nitric oxide synthase (eNOS) for L-arginine substrate. Our hypothesis is that glucose 6-P dehydrogenase (G6PD) overexpression could improve the endothelial function modulating the arginase pathway in aorta from mice. For this study, three groups of male mice were used: young wild type (WT) (6-9 months), old WT (21-22 months) and old G6PD-Tg (21-22 months) mice. Vascular reactivity results showed a reduced acetylcholine-dependent relaxation in the old WT but not old G6PD-Tg group. Endothelial dysfunction was reverted by nor-NOHA, an arginase inhibitor. Mice overexpressing G6PD underexpressed arginase II and also displayed a lower activity of this enzyme. Moreover, histological analyses demonstrated that age causes a thickness of aortic walls, but this did not occur in G6PD-Tg mice. We conclude that the overexpressing G6PD mouse is a model to improve vascular health via the arginase pathway.
Keyphrases
- nitric oxide synthase
- nitric oxide
- wild type
- high fat diet induced
- aortic valve
- healthcare
- cell proliferation
- pulmonary artery
- public health
- mental health
- endothelial cells
- left ventricular
- signaling pathway
- blood pressure
- metabolic syndrome
- pulmonary hypertension
- skeletal muscle
- middle aged
- blood glucose
- pulmonary arterial hypertension